0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Combinations Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27Q7173
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Combinations Market Insights Forecast to 2028
BUY CHAPTERS

Global Vaccine Combinations Market Research Report 2025

Code: QYRE-Auto-27Q7173
Report
July 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaccine Combinations Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vaccine Combinations Market

Vaccine Combinations Market

The global market for Vaccine Combinations was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Combinations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Combinations.
The Vaccine Combinations market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine Combinations market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Combinations companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vaccine Combinations Market Report

Report Metric Details
Report Name Vaccine Combinations Market
CAGR 5%
Segment by Type
  • Two Combinations
  • Three Combinations
  • Four Combinations
  • Six Combinations
Segment by Application
  • Adults
  • Children
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Merck, GlaxoSmithKline, MSD, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vaccine Combinations company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Vaccine Combinations Market report?

Ans: The main players in the Vaccine Combinations Market are Sanofi, Merck, GlaxoSmithKline, MSD, Pfizer

What are the Application segmentation covered in the Vaccine Combinations Market report?

Ans: The Applications covered in the Vaccine Combinations Market report are Adults, Children

What are the Type segmentation covered in the Vaccine Combinations Market report?

Ans: The Types covered in the Vaccine Combinations Market report are Two Combinations, Three Combinations, Four Combinations, Six Combinations

Recommended Reports

Human Vaccine Markets

Vaccine Logistics & Packaging

Adjuvants & Novel Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Combinations Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Two Combinations
1.2.3 Three Combinations
1.2.4 Four Combinations
1.2.5 Six Combinations
1.3 Market by Application
1.3.1 Global Vaccine Combinations Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Combinations Market Perspective (2020-2031)
2.2 Global Vaccine Combinations Growth Trends by Region
2.2.1 Global Vaccine Combinations Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vaccine Combinations Historic Market Size by Region (2020-2025)
2.2.3 Vaccine Combinations Forecasted Market Size by Region (2026-2031)
2.3 Vaccine Combinations Market Dynamics
2.3.1 Vaccine Combinations Industry Trends
2.3.2 Vaccine Combinations Market Drivers
2.3.3 Vaccine Combinations Market Challenges
2.3.4 Vaccine Combinations Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Combinations Players by Revenue
3.1.1 Global Top Vaccine Combinations Players by Revenue (2020-2025)
3.1.2 Global Vaccine Combinations Revenue Market Share by Players (2020-2025)
3.2 Global Vaccine Combinations Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vaccine Combinations Revenue
3.4 Global Vaccine Combinations Market Concentration Ratio
3.4.1 Global Vaccine Combinations Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Combinations Revenue in 2024
3.5 Global Key Players of Vaccine Combinations Head office and Area Served
3.6 Global Key Players of Vaccine Combinations, Product and Application
3.7 Global Key Players of Vaccine Combinations, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Combinations Breakdown Data by Type
4.1 Global Vaccine Combinations Historic Market Size by Type (2020-2025)
4.2 Global Vaccine Combinations Forecasted Market Size by Type (2026-2031)
5 Vaccine Combinations Breakdown Data by Application
5.1 Global Vaccine Combinations Historic Market Size by Application (2020-2025)
5.2 Global Vaccine Combinations Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vaccine Combinations Market Size (2020-2031)
6.2 North America Vaccine Combinations Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vaccine Combinations Market Size by Country (2020-2025)
6.4 North America Vaccine Combinations Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Combinations Market Size (2020-2031)
7.2 Europe Vaccine Combinations Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vaccine Combinations Market Size by Country (2020-2025)
7.4 Europe Vaccine Combinations Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Combinations Market Size (2020-2031)
8.2 Asia-Pacific Vaccine Combinations Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vaccine Combinations Market Size by Region (2020-2025)
8.4 Asia-Pacific Vaccine Combinations Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Combinations Market Size (2020-2031)
9.2 Latin America Vaccine Combinations Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vaccine Combinations Market Size by Country (2020-2025)
9.4 Latin America Vaccine Combinations Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Combinations Market Size (2020-2031)
10.2 Middle East & Africa Vaccine Combinations Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vaccine Combinations Market Size by Country (2020-2025)
10.4 Middle East & Africa Vaccine Combinations Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Vaccine Combinations Introduction
11.1.4 Sanofi Revenue in Vaccine Combinations Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Vaccine Combinations Introduction
11.2.4 Merck Revenue in Vaccine Combinations Business (2020-2025)
11.2.5 Merck Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Vaccine Combinations Introduction
11.3.4 GlaxoSmithKline Revenue in Vaccine Combinations Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 MSD
11.4.1 MSD Company Details
11.4.2 MSD Business Overview
11.4.3 MSD Vaccine Combinations Introduction
11.4.4 MSD Revenue in Vaccine Combinations Business (2020-2025)
11.4.5 MSD Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Vaccine Combinations Introduction
11.5.4 Pfizer Revenue in Vaccine Combinations Business (2020-2025)
11.5.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Vaccine Combinations Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Two Combinations
 Table 3. Key Players of Three Combinations
 Table 4. Key Players of Four Combinations
 Table 5. Key Players of Six Combinations
 Table 6. Global Vaccine Combinations Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Vaccine Combinations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Vaccine Combinations Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Vaccine Combinations Market Share by Region (2020-2025)
 Table 10. Global Vaccine Combinations Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Vaccine Combinations Market Share by Region (2026-2031)
 Table 12. Vaccine Combinations Market Trends
 Table 13. Vaccine Combinations Market Drivers
 Table 14. Vaccine Combinations Market Challenges
 Table 15. Vaccine Combinations Market Restraints
 Table 16. Global Vaccine Combinations Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Vaccine Combinations Market Share by Players (2020-2025)
 Table 18. Global Top Vaccine Combinations Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Combinations as of 2024)
 Table 19. Ranking of Global Top Vaccine Combinations Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Vaccine Combinations Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Vaccine Combinations, Headquarters and Area Served
 Table 22. Global Key Players of Vaccine Combinations, Product and Application
 Table 23. Global Key Players of Vaccine Combinations, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Vaccine Combinations Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Vaccine Combinations Revenue Market Share by Type (2020-2025)
 Table 27. Global Vaccine Combinations Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Vaccine Combinations Revenue Market Share by Type (2026-2031)
 Table 29. Global Vaccine Combinations Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Vaccine Combinations Revenue Market Share by Application (2020-2025)
 Table 31. Global Vaccine Combinations Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Vaccine Combinations Revenue Market Share by Application (2026-2031)
 Table 33. North America Vaccine Combinations Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Vaccine Combinations Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Vaccine Combinations Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Vaccine Combinations Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Vaccine Combinations Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Vaccine Combinations Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Vaccine Combinations Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Vaccine Combinations Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Vaccine Combinations Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Vaccine Combinations Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Vaccine Combinations Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine Combinations Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Vaccine Combinations Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Vaccine Combinations Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Vaccine Combinations Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Sanofi Company Details
 Table 49. Sanofi Business Overview
 Table 50. Sanofi Vaccine Combinations Product
 Table 51. Sanofi Revenue in Vaccine Combinations Business (2020-2025) & (US$ Million)
 Table 52. Sanofi Recent Development
 Table 53. Merck Company Details
 Table 54. Merck Business Overview
 Table 55. Merck Vaccine Combinations Product
 Table 56. Merck Revenue in Vaccine Combinations Business (2020-2025) & (US$ Million)
 Table 57. Merck Recent Development
 Table 58. GlaxoSmithKline Company Details
 Table 59. GlaxoSmithKline Business Overview
 Table 60. GlaxoSmithKline Vaccine Combinations Product
 Table 61. GlaxoSmithKline Revenue in Vaccine Combinations Business (2020-2025) & (US$ Million)
 Table 62. GlaxoSmithKline Recent Development
 Table 63. MSD Company Details
 Table 64. MSD Business Overview
 Table 65. MSD Vaccine Combinations Product
 Table 66. MSD Revenue in Vaccine Combinations Business (2020-2025) & (US$ Million)
 Table 67. MSD Recent Development
 Table 68. Pfizer Company Details
 Table 69. Pfizer Business Overview
 Table 70. Pfizer Vaccine Combinations Product
 Table 71. Pfizer Revenue in Vaccine Combinations Business (2020-2025) & (US$ Million)
 Table 72. Pfizer Recent Development
 Table 73. Research Programs/Design for This Report
 Table 74. Key Data Information from Secondary Sources
 Table 75. Key Data Information from Primary Sources
 Table 76. Authors List of This Report


List of Figures
 Figure 1. Vaccine Combinations Picture
 Figure 2. Global Vaccine Combinations Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine Combinations Market Share by Type: 2024 VS 2031
 Figure 4. Two Combinations Features
 Figure 5. Three Combinations Features
 Figure 6. Four Combinations Features
 Figure 7. Six Combinations Features
 Figure 8. Global Vaccine Combinations Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccine Combinations Market Share by Application: 2024 VS 2031
 Figure 10. Adults Case Studies
 Figure 11. Children Case Studies
 Figure 12. Vaccine Combinations Report Years Considered
 Figure 13. Global Vaccine Combinations Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Vaccine Combinations Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Vaccine Combinations Market Share by Region: 2024 VS 2031
 Figure 16. Global Vaccine Combinations Market Share by Players in 2024
 Figure 17. Global Top Vaccine Combinations Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Combinations as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Vaccine Combinations Revenue in 2024
 Figure 19. North America Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Vaccine Combinations Market Share by Country (2020-2031)
 Figure 21. United States Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Vaccine Combinations Market Share by Country (2020-2031)
 Figure 25. Germany Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Vaccine Combinations Market Share by Region (2020-2031)
 Figure 33. China Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Vaccine Combinations Market Share by Country (2020-2031)
 Figure 41. Mexico Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Vaccine Combinations Market Share by Country (2020-2031)
 Figure 45. Turkey Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Vaccine Combinations Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Sanofi Revenue Growth Rate in Vaccine Combinations Business (2020-2025)
 Figure 49. Merck Revenue Growth Rate in Vaccine Combinations Business (2020-2025)
 Figure 50. GlaxoSmithKline Revenue Growth Rate in Vaccine Combinations Business (2020-2025)
 Figure 51. MSD Revenue Growth Rate in Vaccine Combinations Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Vaccine Combinations Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS